Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ) released earnings for first quarter of RMB28.18 million
The company's bottom line totaled RMB28.18 million, or RMB0.02 per share. This compares with RMB24.16 million, or RMB0.02 per share, last year.
The company's revenue for the period fell 15.3% to RMB644.12 million from RMB760.58 million last year.
Guizhou Bailing Group Pharmaceutical Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB28.18 Mln. vs. RMB24.16 Mln. last year.-EPS: RMB0.02 vs. RMB0.02 last year.-Revenue: RMB644.12 Mln vs. RMB760.58 Mln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.